Dr. Anusha Thumma | Pharmaceutical Sciences | Best Researcher Award

scientist at nova southeastern university, United States

Dr. Anusha Thumma holds a Ph.D. in Pharmaceutical Sciences and specializes in drug formulation, abuse-deterrent technologies, inhalation products, and vaccine adjuvants. With expertise in HPLC, qPCR, ELISA, DSC, and flow cytometry, she ensures regulatory compliance with FDA, ICH, GMP, and GLP standards. She has worked as an Associate Scientist at Lupin Pharmaceuticals, an R&D Scientist at US Pharma LTD, and an Associate Professor at Radex Regulatory Affairs. Her research includes mRNA vaccine lipid nanoparticles and opioid abuse-deterrent formulations. She excels in project management, data analysis (Minitab), and cross-functional collaboration.

🎓 Education

Dr. Anusha Thumma holds a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from Nova Southeastern University, USA (2023), where her dissertation focused on Abuse-Deterrent Composites: A Multi-Angle Approach. She earned her Master of Pharmacy (MPharm) from Osmania University, India (2013), specializing in Formulation and Characterization of Imiquimod Multiple Emulsion as a Novel Vaccine Delivery System. Her academic journey began with a Bachelor of Pharmacy (BPharm) from Kakatiya University, India (2011). With a strong foundation in pharmaceutical sciences, her research contributions span drug formulation, regulatory affairs, and vaccine development. 💊🔬

🏆 Academic Excellence & Professional Achievements

Dr. Anusha Thumma has been recognized with multiple prestigious scholarships and grants for her outstanding academic and research contributions. She received a fully funded PhD scholarship and a PhD Scholar Stipend from Nova Southeastern University, USA, along with the President’s Faculty Research and Development Grant and HPD Research Grant for her research excellence. She also secured fully funded scholarships for her Master’s (Osmania University) and Bachelor’s (Kakatiya University) degrees in India. Additionally, she holds a Professional Diploma in Regulatory Affairs (USA), is a Registered Pharmacist (India), and has attended webinars on drug discovery. 📜🎓💊

🔬 Research Focus Areas

Dr. Anusha Thumma’s research primarily focuses on environmental remediation 🌱, pharmaceutical sciences 💊, and drug abuse potential 🧪. She has made significant contributions to water purification by exploring biochar-based adsorption for removing heavy metals (cadmium, zinc, arsenic) and dyes from polluted water. Her expertise extends to pharmaceutical formulations, particularly in abuse-deterrent drug delivery systems. Additionally, she investigates the toxicity and abuse potential of fentanyl analogues. Her interdisciplinary work integrates biopolymer-based cryostructures, advancing biomedical and pharmaceutical applications. Through her research, she aims to enhance sustainable environmental solutions and safer pharmaceutical formulations. 🌍🔬💧

Publication Top Notes

Adsorptive removal of arsenic from drinking water using KOH-modified sewage sludge-derived biochar
Exploring the efficiency of sodium alginate beads and Cedrus deodara sawdust for adsorptive removal of crystal violet dye
Advances in cryostructures and their applications in biomedical and pharmaceutical products
Abuse potential of fentanyl and fentanyl analogues
Removal of cadmium and zinc from water using sewage sludge-derived biochar
Potential of easily available low-cost raw cotton for the elimination of methylene blue dye from polluted water

Ashwin Kuchekar | Pharmaceutics | Best Researcher Award

Professor Ashwin Kuchekar School of Health Sciences and Technology at India.

Dr. Ashwin Kuchekar is the Associate Dean (Academic and Faculty Affairs) and a Professor at the School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune. With extensive experience in both academia and industry, he focuses on enhancing research, management, and administration within the pharmaceutical sector. His expertise spans pharmaceutical formulation, development, and quality by design. Dr. Kuchekar is committed to bridging the gap between industry and academia through innovative teaching and robust industry partnerships.

PUBLICATION PROFILE:

google scholar

Education:

Ph.D. in Pharmaceutics (Pharmaceutical Sciences)
Bharati Vidyapeeth University, Pune, India (2010-2015)
Dissertation: Development and Evaluation of Targeted Polymeric Micellar Drug Delivery System
Guide: Prof. Atmaram Pawar
Master of Pharmacy (Pharmaceutics)
R. C. Patel Institute of Pharmaceutical Education & Research, Shirpur, North Maharashtra University, India (2009)
Dissertation: Formulation and Evaluation of Chronotherapeutic Drug Delivery Systems
Guide: Dr. Surendra Gattani
Bachelor of Pharmacy
Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, India (2007)
HSC
Sadguru Gadge Maharaj College, Vidyanagar, Karad, Kolhapur Board, India (2003)
SSC
Holy Family Convent High School, Vidyanagar, Karad, Kolhapur Board, India (2001)

Experience:

Associate Dean (Academic and Faculty Affairs) & Professor
Dr. Vishwanath Karad MIT World Peace University, Pune (June 2023 – Present)
Responsibilities include teaching B. Pharm. and M. Pharm. students, guiding research projects, managing the pilot plant, and overseeing training, placement, and industry partnerships.
Associate Professor
Dr. Vishwanath Karad MIT World Peace University, School of Pharmacy, Pune (June 2019 – June 2023)
Lecturer – Pharmaceutics
Progressive Education Society’s, Modern College of Pharmacy (For Ladies), Moshi, Pune (Nov 2009 – Aug 2010)
Industrial Experience:
Innovation and Development at Abbott Healthcare Pvt. Ltd., Mumbai (Sep 2016 – Jun 2019)
Formulation and Development at Lupin Research Park, Pune (Aug 2014 – Sep 2016)
Formulation and Development at Piramal Health Care, Mumbai (May 2009 – Nov 2009)
Formulation and Development at Nu-Life Pharmaceuticals, Pune (May 2006 – Jun 2006)

Research Focus:

Dr. Ashwin Kuchekar’s research is dedicated to advancing the field of pharmaceutics with a focus on innovative drug delivery systems and formulation development. His work encompasses a range of topics within pharmaceutical sciences, emphasizing the creation of novel technologies and methodologies to improve therapeutic efficacy and patient outcomes. Key areas of his research include:

1. Drug Delivery Systems
Dr. Kuchekar explores cutting-edge methods for optimizing drug delivery, including:
Orally Disintegrating Tablets: Development and evaluation of tablets that rapidly dissolve in the mouth, enhancing patient compliance.
Nanoparticle-Based Delivery: Use of nanoparticles to improve the solubility and bioavailability of drugs, and to target specific sites within the body.
2. Innovative Formulation Technologies
His research investigates novel formulation techniques to address challenges in pharmaceutical development, such as:
Cocrystallization: Enhancing drug properties through the formation of cocrystals to improve solubility and stability.
Hydrotropic Solubilization: Using hydrotropic agents to increase the solubility of poorly soluble drugs.
3. Anticoagulant Research
Dr. Kuchekar has made significant contributions to the field of anticoagulants, including:
In Vivo Evaluation: Assessing the anticoagulant activity of new formulations and technologies to improve treatment outcomes for patients at risk of thromboembolic events.
4. Green and Sustainable Chemistry
He focuses on environmentally friendly approaches, such as:
Green Synthesized Nanoparticles: Development of silver nanoparticles using plant extracts, contributing to sustainable practices in pharmaceutical research.
5. Pediatric Drug Delivery
Dr. Kuchekar is also involved in research aimed at improving drug delivery systems for pediatric patients, addressing unique challenges in formulation and administration.
Dr. Kuchekar’s work is characterized by its emphasis on practical, real-world applications of pharmaceutical science, aiming to bridge the gap between research innovations and clinical practice to benefit patients and healthcare providers alike.

Research Interests:

Pharmaceutics and Drug Delivery Systems: Development and optimization of novel drug delivery systems, including targeted and controlled-release formulations. This includes the use of polymeric micelles, cocrystallization technology, and chronotherapeutic systems to improve drug efficacy and patient compliance.
Nanotechnology in Medicine: Application of nanotechnology in pharmaceutical formulations, such as green synthesis of nanoparticles for therapeutic use, and the development of dry powder inhalers.
Anticoagulant and Cardiovascular Drugs: Research on the formulation and evaluation of anticoagulant drugs, including the development of innovative dosage forms like matrix tablets and cocrystals to enhance their therapeutic potential.
Oncology: Exploration of new treatment strategies for various cancers, including triple-negative breast cancer, focusing on novel therapeutic approaches and their mechanisms of action.
Precision Medicine: Implementation of precision medicine approaches in the treatment of allergic rhinitis and other conditions, emphasizing individualized therapy based on patient-specific factors.
Skin Rejuvenation and Retinoids: Study of novel drug delivery systems for retinoids to improve skin rejuvenation and address age-related skin changes.
mRNA Vaccine Development: Investigation of lipid nanoparticles and other delivery systems in the development and optimization of mRNA vaccines for infectious diseases and other medical applications.

Anusha Thumma | Pharmaceutical Sciences| Best Researcher Award

Dr. Anusha Thumma | Pharmaceutical Sciences | Best Researcher Award

Publication Profile

🎓 Education